Mediwatch PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Mediwatch PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Mediwatch PLC. The Group's principal activity is developing primary care products used in the diagnosis of urological disorders and early prostate cancer detection. Its operation focuses on such areas urology, bladder assessment, erectile dysfunction, urogynaecology, incontinence and near-patient testing. The Group operates in three divisions: ultrasound, urodynamics and biochemistry. Its products include Portascan+, Multiscan and Multiscan PVR in ultrasound; Urodyn 1000, Portaflow, Duet Logic G2, Duet Encompass and Duet Logic Sensic G3, Disposables and Erectease in urodynamics and PSAWatch, Bioscan and BTA in biochemistry. The Group operates predominantly in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report